These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3671730)
1. Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism. Smith JB; Yanagisawa A; Zipkin R; Lefer AM Prostaglandins; 1987 Jun; 33(6):777-82. PubMed ID: 3671730 [TBL] [Abstract][Full Text] [Related]
2. Antagonism of thromboxane actions in the isolated perfused rat heart. Stahl GL; Darius H; Lefer AM Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431 [TBL] [Abstract][Full Text] [Related]
3. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Quilley J; McGiff JC; Nasjletti A Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332 [TBL] [Abstract][Full Text] [Related]
4. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565 [No Abstract] [Full Text] [Related]
5. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells. Miki I; Kase H; Ishii A Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R; Mezzasoma AM; Venditti G; Gresele P Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [TBL] [Abstract][Full Text] [Related]
7. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Okwu AK; Mais DE; Halushka PV Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280 [TBL] [Abstract][Full Text] [Related]
8. Effect of thromboxane A2/endoperoxide antagonist SQ29548 on the contractile response to acetylcholine in newborn piglet cerebral arteries. Wagerle LC; Busija DW Circ Res; 1990 Mar; 66(3):824-31. PubMed ID: 2306808 [TBL] [Abstract][Full Text] [Related]
9. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes. Mais DE; Saussy DL; Magee DE; Williams CM Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567 [No Abstract] [Full Text] [Related]
10. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition. Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042 [TBL] [Abstract][Full Text] [Related]
11. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [TBL] [Abstract][Full Text] [Related]
12. Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation. Aksoy MO; Harakal C; Smith JB; Stewart GJ; Zerweck CR Br J Pharmacol; 1990 Mar; 99(3):461-6. PubMed ID: 2110015 [TBL] [Abstract][Full Text] [Related]
13. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
14. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo. Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979 [TBL] [Abstract][Full Text] [Related]
15. Actions of SQ 29,548 on contractile responses and arachidonic acid metabolism of intrapulmonary arteries, in vitro. Boyd VL; Kvamme P; Harbison R; Kadowitz PJ; McNamara DB Agents Actions; 1992 Mar; 35(3-4):280-8. PubMed ID: 1529803 [TBL] [Abstract][Full Text] [Related]
16. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555 [TBL] [Abstract][Full Text] [Related]
17. Identification of functional PGH2/TxA2 receptors on human endothelial cells. Kent KC; Collins LJ; Schwerin FT; Raychowdhury MK; Ware JA Circ Res; 1993 May; 72(5):958-65. PubMed ID: 8477529 [TBL] [Abstract][Full Text] [Related]
18. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion. Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517 [TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Huang A; Sun D; Koller A Hypertension; 1993 Dec; 22(6):913-21. PubMed ID: 8244524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]